Available NowMetabolic Research
TIRZEPATIDE
Dual Incretin Receptor Agonist
CAS 2023788-19-2 ≥99.0% purity verified
Tirzepatide is a synthetic dual incretin receptor agonist with significant interest in metabolic research. Supplied as lyophilized powder with batch-specific COA.
About TIRZEPATIDE
Tirzepatide is a 39-amino acid synthetic peptide that acts simultaneously at GIP and related incretin receptors. The dual receptor mechanism makes it a compound of considerable research interest in metabolic studies.
Research applications
- Dual incretin receptor pharmacology
- Metabolic and energy homeostasis research
- Comparative receptor agonist activity studies
- In-vitro receptor binding and signaling assays
| Product name | TIRZEPATIDE |
| CAS number | 2023788-19-2 |
| Purity | ≥99.0% (HPLC verified) |
| Format | Lyophilized powder |
| Testing | HPLC, LC-MS, endotoxin |
| Accreditation | ISO/IEC 17025 third-party lab |
| Origin | GMP-certified synthesis facility |
Storage guidelines
- Store at −20°C in original sealed vial, away from light and moisture
- Stable for 24+ months under proper conditions
- After reconstitution: store at −80°C, aliquot to avoid freeze-thaw cycles
Independent testing & verification
Every batch tested by an independent ISO/IEC 17025-accredited lab before release.
- HPLC purity analysis — confirms ≥99.0% with full chromatogram
- LC-MS molecular weight — confirms correct molecular identity
- Endotoxin testing — LAL assay per USP standards
Select size
Order total$29.95
≥99.0% purity, COA included
Dispatched within 48 hours or less
Free shipping over $250
GMP-sourced, 3rd-party tested